Correction: Targeting immuno-oncology metabolism for precision cancer therapy [0.03%]
特写：精准肿瘤治疗的免疫代谢靶向疗法纠正论文
Sakshi Pajai,Jyoti E John,Satyendra Chandra Tripathi
Sakshi Pajai
[This corrects the article DOI: 10.3389/fonc.2023.1124715.]. Keywords: cancer; immune cells; immuno-oncology...
Published Erratum
Frontiers in oncology. 2026 Jan 12:15:1764570. DOI:10.3389/fonc.2025.1764570 2026
Coactivator networks orchestrating noncanonical AR programs in enzalutamide-resistant CRPC [0.03%]
共激活剂网络在恩杂卢胺耐药性CRPC中协调非经典AR程序
Ephraim J Gardner,Sasikumar Ponnusamy,Remi Adelaiye-Ogala
Ephraim J Gardner
Resistance to androgen receptor (AR)-targeted therapies remains a major clinical challenge in the treatment of castration-resistant prostate cancer (CRPC). Emerging evidence suggests that Enzalutamide resistance is not solely due to the los...
Clival metastasis of hepatocellular carcinoma: a case report of a rare skull-base malignancy [0.03%]
肝细胞癌经岩斜区转移一例罕见颅底肿瘤的病例报告
Tomislav Felbabić,Roman Bošnjak,Jure Urbančič et al.
Tomislav Felbabić et al.
Introduction: Hepatocellular carcinoma is the most common neoplasm of the liver. It metastasizes mainly to local lymph nodes, lungs, adrenal glands, vertebrae, pelvis, ribs and long bones. Metastasis to the clivus is extr...
A retroperitoneal urinoma secondary to metastatic urothelial carcinoma mimicking psoas muscle malignancy: Case Report and literature review [0.03%]
次发于转移性尿路上皮癌的腹膜后尿囊肿继发误诊为髂腰肌恶性肿瘤：病例报告及文献回顾
Tianping Li,Haijuan Lv
Tianping Li
Purpose: This study aims to improve the understanding of imaging features of urinoma associated with urothelial carcinoma metastasis, enhance preoperative diagnostic accuracy, and reduce misdiagnosis rates. ...
Sintilimab combined with AVD for the treatment of composite Hodgkin lymphoma and follicular lymphoma: a case report and literature review [0.03%]
信迪利单抗联合AVD方案治疗混合型霍奇金淋巴瘤及边缘区淋巴瘤1例并文献复习
Huami Ye,Linlin Huang,Changqian Chen et al.
Huami Ye et al.
Composite lymphoma has been rarely reported due to its low incidence. The treatment of composite lymphoma depends on the specific lymphoma subtypes involved. No standardized therapeutic regimen has been established. We tried to treat the pa...
Utility and clinical effectiveness of liquid biopsy-based DNA methylation testing in early tumor screening and diagnosis, emphasizing older adult populations: a systematic review and meta-analysis [0.03%]
基于液体活检的DNA甲基化检测在早期肿瘤筛查和诊断中的效用及临床效果：一项系统综述和荟萃分析
Yujuan Gao,Haoyu Xu,Juan Li et al.
Yujuan Gao et al.
Background: The global aging population faces a disproportionate burden of lung cancer, creating an urgent need for minimally invasive screening methods. Liquid biopsy-based DNA methylation testing, particularly targeting...
A two-stage deep learning prediction system for colon cancer microsatellite instability status using CT images [0.03%]
基于CT影像的结直肠癌微卫星不稳定性状态预测的两阶段深度学习系统
Songlin Cui,Xin Xiong,Xudong Yang et al.
Songlin Cui et al.
Background: This study seeks to build a two-stage deep learning approach for identifying the microsatellite instability (MSI) status of colon cancer based on computed tomography (CT) scans without the requirement for manu...
Predicting lung metastasis after radical colorectal cancer surgery: a two center retrospective cohort study and nomogram development [0.03%]
预测结直肠癌根治术后肺转移的列线图模型建立：一项多中心回顾性队列研究
Yun Liang,Zichang Ma,Siquan Zhong et al.
Yun Liang et al.
Background: Colorectal cancer (CRC) is a leading cause of cancer-related death, with distant metastasis being the primary driver of mortality. Lung metastases are among the most frequent sites of extra-abdominal metastasi...
Determining optimal clinical target volume margins based on microscopic tumor extension in patients with non-small-cell lung cancer undergoing chemotherapy or chemotherapy combined with immunotherapy [0.03%]
基于接受化学治疗或化疗联合免疫治疗的非小细胞肺癌患者微转移病灶范围确定最佳临床靶量边缘位置
Yujiao Zhang,Xiao Song,Jiaran Li et al.
Yujiao Zhang et al.
Background: There is currently no unified understanding of the clinical target volume (CTV) margins for radiotherapy in non-small cell lung cancer (NSCLC), after chemotherapy or chemotherapy combined with immunotherapy. T...
Prognostic value of LDH and α-HBDH dynamic levels for 1-year overall survival and progression-free survival in patients with extensive-stage small-cell lung cancer treated with chemoimmunotherapy [0.03%]
LDH和α-HBDH动态水平对广泛期小细胞肺癌化疗免疫治疗1年总生存率及无进展生存率的预后价值
Wanjing Li,Guochang Du,Shuangqing Lu et al.
Wanjing Li et al.
Background: Extensive-stage small cell lung cancer (ES-SCLC) remains a lethal malignancy with limited prognostic biomarkers. This study evaluated the prognostic utility of lactate dehydrogenase (LDH) and α-hydroxybutyrat...